pfk13-Independent Treatment Failure in Four Imported Cases of Plasmodium falciparum Malaria Treated with Artemether-Lumefantrine in the United Kingdom

被引：0

作者：

Sutherland, Colin J. ^{[1
,2
]}

Lansdell, Paul ^{[1
]}

Sanders, Mandy ^{[3
]}

Muwanguzi, Julian ^{[2
]}

van Schalkwyk, Donelly A. ^{[2
]}

Kaur, Harparkash ^{[2
]}

Nolder, Debbie ^{[1
]}

Tucker, Julie ^{[1
]}

Bennett, Hayley M. ^{[3
]}

Otto, Thomas D. ^{[3
]}

Berriman, Matthew ^{[3
]}

Patel, Trupti A. ^{[4
]}

Lynn, Roderick ^{[5
]}

Gkrania-Klotsas, Effrossyni ^{[6
]}

Chiodini, Peter L. ^{[1
,4
]}

机构：

[1] London Sch Hyg & Trop Med, Publ Hlth England Malaria Reference Lab, London, England

[2] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London, England

[3] Wellcome Trust Sanger Inst, Hinxton, England

[4] Hosp Trop Dis, London, England

[5] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Dept Haematol, Cambridge, England

[6] Cambridge Univ Hosp NHS Fdn Trust, Dept Infect Dis, Addenbrookes Hosp, Cambridge, England

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2017年 / 61卷 / 03期

基金：

英国惠康基金;

关键词：

imported malaria; treatment failure; parasite genotyping; antimalarial agents; drug resistance mechanisms; UNCOMPLICATED MALARIA; ARTEMISININ; RESISTANCE;

D O I：

10.1128/AAC.02382-16

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We present case histories of four patients treated with artemether-lumefantrine for falciparum malaria in UK hospitals in 2015 to 2016. Each subsequently presented with recurrent symptoms and Plasmodium falciparum parasitemia within 6 weeks of treatment with no intervening travel to countries where malaria is endemic. Parasite isolates, all of African origin, harbored variants at some candidate resistance loci. No evidence of pfk13-mediated artemisinin resistance was found. Vigilance for signs of unsatisfactory antimalarial efficacy among imported cases of malaria is recommended.

引用

页数：5

共 44 条

[21] K13 Propeller Alleles, mdr1 Polymorphism, and Drug Effectiveness at Day 3 after Artemether-Lumefantrine Treatment for Plasmodium falciparum Malaria in Colombia, 2014-2015
Montenegro, Madeline
Neal, Aaron T.
Posada, Maritza
De las Salas, Briegel
Lopera-Mesa, Tatiana M.
Fairhurst, Rick M.
Tobon-Castano, Alberto
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (12)
[22] Safety and therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria at Shecha health centre, Arba Minch, Ethiopia
Kale Gubae
Hussein Mohammed
Heven Sime
Henok Hailgiorgis
Anteneh Kassahun Mare
Bokretsion Gidey
Mebrahtom Haile
Gudissa Assefa
Worku Bekele
Geremew Tasew
Solomon Mequanente Abay
Ashenafi Assefa
Malaria Journal, 22
[23] A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa
Onyamboko, Marie A.
Hoglund, Richard M.
Lee, Sue J.
Kabedi, Charlie
Kayembe, Daddy
Badjanga, Benjamin B.
Turner, Gareth D. H.
Jackson, Nikky, V
Tarning, Joel
McGready, Rose
Nosten, Francois
White, Nicholas J.
Day, Nicholas P. J.
Fanello, Caterina
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
[24] High Rate of Treatment Failures in Nonimmune Travelers Treated With Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria in Sweden: Retrospective Comparative Analysis of Effectiveness and Case Series
Sonden, Klara
Wyss, Katja
Jovel, Irina
da Silva, Antero Vieira
Pohanka, Anton
Asghar, Muhammad
Homann, Manijeh Vafa
Gustafsson, Lars L.
Hellgren, Urban
Farnert, Anna
CLINICAL INFECTIOUS DISEASES, 2017, 64 (02) : 199 - 206
[25] Molecular Detection of Residual Parasitemia after Pyronaridine-Artesunate or Artemether-Lumefantrine Treatment of Uncomplicated Plasmodium falciparum Malaria in Kenyan Children
Roth, Johanna M.
Sawa, Patrick
Omweri, George
Makio, Nicodemus
Osoti, Victor
de Jong, Menno D.
Schallig, Henk D. F. H.
Mens, Petra F.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2018, 99 (04) : 970 - 977
[26] Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study
Vaughan-Williams, Charles H.
Raman, Jaishree
Raswiswi, Eric
Immelman, Etienne
Reichel, Holger
Gate, Kelly
Knight, Steve
MALARIA JOURNAL, 2012, 11
[27] Artemether–lumefantrine treatment failure despite adequate lumefantrine day 7 concentration in a traveller with Plasmodium falciparum malaria after returning from Tanzania
Anna Färnert
Johan Ursing
Thomas Tolfvenstam
Josea Rono
Lillemor Karlsson
Elda Sparrelid
Niklas Lindegårdh
Malaria Journal, 11
[28] Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study
Chandra, Richa
Ansah, Patrick
Sagara, Issaka
Sie, Ali
Tiono, Alfred B.
Djimde, Abdoulaye A.
Zhao, Qinying
Robbins, Jeffery
Penali, Louis K.
Ogutu, Bernhards
MALARIA JOURNAL, 2015, 14
[29] Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study
Richa Chandra
Patrick Ansah
Issaka Sagara
Ali Sie
Alfred B Tiono
Abdoulaye A Djimde
Qinying Zhao
Jeffery Robbins
Louis K Penali
Bernhards Ogutu
Malaria Journal, 14
[30] Therapeutic efficacy and safety of artemether-lumefantrine combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria at Teda Health Centre, Northwest Ethiopia, 2022/23
Woldesenbet, Dagmawi
Birhanie, Meseret
Abere, Aberham
Zeleke, Ayalew Jejaw
Bezabih, Migbaru Keffale
Semaw, Muluken
Wubetie, Menberu
Abebe, Wagaw
Tamene, Elias
Tegegne, Yalewayker
MALARIA JOURNAL, 2024, 23 (01)

← 1 2 3 4 5 →